AI assistant
Sending…
EBOS GROUP LIMITED — Director's Dealing 2016
Nov 14, 2016
64813_rns_2016-11-14_d57145fa-3326-4be6-9f17-e6505011a302.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [98 x 27] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 15-Nov-16 | |
| Date of last disclosure: | 27-Sep-16 | |
| Director or senior manager giving disclosure | ||
Full name(s): |
Sean Duggan | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Chief Executive Officer,Animal Care |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- Number held in class before acquisition or disposal: Number held in class after acquisition or disposal: Current registered holder(s): |
Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- Number held in class before acquisition or disposal: Number held in class after acquisition or disposal: Current registered holder(s): |
|
|---|---|---|
| Class ofaffected quotedfinancialproducts: | Ordinaryshares in EBOS GroupLimited | |
| Nature of the affected relevant interest(s): | Correction to Ongoing Disclosure Notice lodged on 27 September 2016. |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | The number of shares held before the acquisition of shares disclosed on 27 September 2016 was 306 ordinaryshares. |
|
| Number held in class after acquisition or disposal: | The number of shares held following the acquisition of shares disclosed on 27 September 2016 is 45,306 ordinaryshares. |
|
| Current registered holder(s): | Sean Duggan | |
| Registeredholder(s) once transfers areregistered: | Sean Duggan | |
| Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab | le) | |
| Type of affected derivative: | N/A | |
| Class of underlyingfinancialproducts: | N/A | |
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
N/A | |
| A statement as to whether the derivative is cash settled orphysicallysettled: | N/A | |
| Maturitydate of the derivative(if any): | N/A | |
| Expirydate of the derivative(if any): | N/A | |
| Theprice specified in the terms of the derivative(if any): | N/A | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: |
N/A | |
| _For that derivative,- _ | ||
| Parties to the derivative: | N/A | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
N/A | |
| Details of transactions giving rise to acquisition or disposal | ||
| Total numberoftransactions towhich noticerelates: | Please refer to 27 September 2016 notice. | |
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):
| If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— |
|||
|---|---|---|---|
| Whether relevantinterestswere acquired ordisposed ofduring a closed period: | No | ||
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod: |
N/A | ||
| Date of theprior written clearance(if any): | N/A | ||
| Summary of other relevant interests after acquisition or disposal: Class ofquotedfinancialproducts: Nature of relevant interest: For that relevant interest,- Number heldinclass: Currentregisteredholder(s): For a derivative relevant interest,- Type ofderivative: Details of derivative,- |
|||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
N/A | ||
| A statement as to whether the derivative is cash settled or physically settled: | N/A | ||
| Maturity date of the derivative (if any): | N/A | ||
| Expiry date of the derivative (if any): | N/A | ||
| The price's specified terms (if any): | N/A | ||
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: |
N/A | ||
| For that derivative relevant interest,- | N/A | ||
| Parties to the derivative: | N/A | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
N/A |
Certification
| I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. |
||
|---|---|---|
| Signature of director or officer: | ||
| Date of signature: | ||
| or | ||
| Signature of person authorised to sign on behalf of director or officer: | ||
| Date of signature: | 15-Nov-16 | |
| Name and title of authorised person: | Janelle Cain, General Counsel, EBOS Group Limited |
|
More from EBOS GROUP LIMITED
Share Issue/Capital Change
2026
May 18
Share Issue/Capital Change
2026
May 18
Share Issue/Capital Change
2026
May 17
Share Issue/Capital Change
2026
May 17
Share Issue/Capital Change
2026
May 17
Share Issue/Capital Change
2026
May 17
Capital/Financing Update
2026
May 6
Share Issue/Capital Change
2026
May 5
Capital/Financing Update
2026
May 5
Regulatory Filings
2026
May 1